Clinical Trials and Cohort Studies Grants support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health. 

This funding scheme is open to research proposals for clinical trials and/or cohort studies of any size – that is, they may be large or small clinical trials or cohort studies. 

The intended outcomes of the Clinical Trials and Cohort Studies Grants scheme are improvements in health and well-being, health care practice or policy, as a result of:

  • High-quality clinical trials that provide reliable evidence of the effects of health-related interventions on health outcomes (or appropriate surrogates).
  • High-quality cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.
  • High quality retrospective cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.


If you will be applying for a Clinical Trial Cohort Studies Grant and have not yet registered for a Sapphire account you will need to register

Where to go for assistance 

Resources are available to assist you in navigating Sapphire, such as Help (a list of frequently asked questions), how-to videos and access to the Sapphire Help Desk. The Sapphire Helpdesk will be available by email and telephone to assist you with any questions and issues.

National Health and Medical Research Council (NHMRC) will update Sapphire with the latest news and other relevant information. We encourage you to check back regularly to keep yourself informed.

Funding support

Clinical Trials and Cohort Studies Grants may be funded by or in conjunction with other organisations. These grants offer opportunities to researchers whose work is particularly relevant to the priorities and research interests of the partner organisations.

For the Clinical Trials and Cohort Studies Grants 2022 opportunity, the funding partner/s include:

•    Cancer Australia & Funding Partners.

Peer Review information

Applications to the Clinical Trials and Cohort Studies Grants 2022 opportunity will be assessed in accordance with the assessment criteria set out in the Grant Guidelines that are now available on GrantConnect. The category descriptors are also provided within the Grant Guidelines.
 
For details regarding the Clinical Trials and Cohort Studies 2022 peer review process, the Peer Review Guidelines are now available on GrantConnect.

Grant at a glance

Duration of funding
1 - 5 years

Before you submit an application, please make sure you have:

1

Grant submission advice

Read all relevant reference material

GrantConnect GO Documents

2

Liaise with your Administering Institution

to identify any specific requirements that the institution may have

3

Ensure your application is complete and correct.